Delivery Order SPE2DB22D2214-SPE2DB25FS6LT
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg with a ceiling value of $1,910.48 under a firm fixed-price contract. The award, issued on September 9, 2025, with an ultimate completion date of September 10, 2025, represents a non-competitive delivery against an existing contract vehicle. Performance will be executed from the contractor's Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a contract ceiling value of $11,539.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate...
- The Defense Logistics Agency (DLA) awarded a $5,978.22 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100-count) valued at $6,601.92. This non-competitive, firm fixed-price delivery order was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This award represents a routine pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,899.43 to AmerisourceBergen Drug Corp for the supply of Concerta ER 18 mg tablets (100 count) on August 11, 2025, with ultimate completion by August 12, 2025. This firm fixed price delivery order carries no set-aside designation and was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $19,690.75 to AmerisourceBergen Drug Corp for the supply of Concerta ER 36 mg tablets (100 count) under a firm fixed price contract. This non-set-aside award was issued on July 25, 2025, with an ultimate completion date of July 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $47,631.00 for 100 tablets of Concerta ER 54 mg on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price, competitively awarded contract (with no set-aside designation) represents a pharmaceutical supply delivery under the company's existing DLA contract vehicle. The medication will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,475.54 to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Concerta ER 18 mg tablets (100-count package). This is a firm fixed-price, non-set-aside contract with a completion date of September 12, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Concerta ER 54 mg tablets (100-count supply) valued at $9,061.87 under a firm fixed price contract. The award, issued on July 21, 2025, with an ultimate completion date of July 22, 2025, represents a non-competitive delivery against the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. AmerisourceBergen Drug Corp,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) with a ceiling value of $9,672.59. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by August 4, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for...
- SPE2DB22D2214Indefinite Delivery Contract
- SPE2DB22D2214-SPE2DB25FS6LTDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Concerta ER 27 mg tablets (100-count) with a ceiling value of $1,801.16. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's primary hub for pharmaceutical distribution operations supporting federal medical procurement. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle provides comprehensive pharmaceutical support globally, enabling AmerisourceBergen to supply a broad range of medications, vaccines, medical devices, and healthcare commodities to support military healthcare programs. The company's significant IDC capacity and demonstrated track record across multiple therapeutic domains position it as a critical vendor for federal medical supply needs serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 9/8/25 |